Cargando…

Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy

BACKGROUND: The aim of this study was to explore the relationship between C-reactive protein (CRP) and respiratory diseases in patients with diabetic retinopathy. MATERIAL/METHODS: We identified 855 patients with diabetic retinopathy who met the inclusion criteria from the “Diabetes Complications Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kejia, Yan, Jiamin, Wu, Ling, Gu, Xingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123838/
https://www.ncbi.nlm.nih.gov/pubmed/35578564
http://dx.doi.org/10.12659/MSM.935807
_version_ 1784711636597080064
author Chen, Kejia
Yan, Jiamin
Wu, Ling
Gu, Xingbo
author_facet Chen, Kejia
Yan, Jiamin
Wu, Ling
Gu, Xingbo
author_sort Chen, Kejia
collection PubMed
description BACKGROUND: The aim of this study was to explore the relationship between C-reactive protein (CRP) and respiratory diseases in patients with diabetic retinopathy. MATERIAL/METHODS: We identified 855 patients with diabetic retinopathy who met the inclusion criteria from the “Diabetes Complications Data Set” in the National Population Health Data Center. We divided patients into 3 groups according to CRP tertiles: Q1 (<0.3 mg/dL), Q2 (0.3–0.35 mg/dL), and Q3 (>0.35 mg/dL). A multivariate logistic regression model was used to evaluate the relationship between CRP and respiratory diseases. The area under the receiver operating characteristic (ROC) curve was used to investigate the independent predictive effect of CRP on respiratory diseases. RESULTS: Of the 855 patients with diabetic retinopathy, 137 (16%) had respiratory diseases. Prevalence of respiratory diseases gradually increased with an increase in CRP level (P for trend=0.001). With CRP as a continuous variable in the logistic regression model adjusted for confounding factors (model 3), the odds ratio (OR) per 1 standard deviation increment of CRP was 1.25 (95% CI 1.07–1.45, P=0.004). When the lowest CRP tertile group was used as the reference group, the OR of the highest CRP tertile group was 1.99 (95% CI 1.22–1.3.26, P=0.006). Adding CRP to the risk factor model increased the area under the ROC curve (0.68 vs 0.65, P=0.017). Subgroup analysis showed that the relationship between CRP and respiratory diseases had no potential heterogeneity among subgroups. CONCLUSIONS: CRP can be used as an effective biomarker in predicting risk of respiratory diseases in patients with diabetic retinopathy.
format Online
Article
Text
id pubmed-9123838
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-91238382022-06-10 Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy Chen, Kejia Yan, Jiamin Wu, Ling Gu, Xingbo Med Sci Monit Database Analysis BACKGROUND: The aim of this study was to explore the relationship between C-reactive protein (CRP) and respiratory diseases in patients with diabetic retinopathy. MATERIAL/METHODS: We identified 855 patients with diabetic retinopathy who met the inclusion criteria from the “Diabetes Complications Data Set” in the National Population Health Data Center. We divided patients into 3 groups according to CRP tertiles: Q1 (<0.3 mg/dL), Q2 (0.3–0.35 mg/dL), and Q3 (>0.35 mg/dL). A multivariate logistic regression model was used to evaluate the relationship between CRP and respiratory diseases. The area under the receiver operating characteristic (ROC) curve was used to investigate the independent predictive effect of CRP on respiratory diseases. RESULTS: Of the 855 patients with diabetic retinopathy, 137 (16%) had respiratory diseases. Prevalence of respiratory diseases gradually increased with an increase in CRP level (P for trend=0.001). With CRP as a continuous variable in the logistic regression model adjusted for confounding factors (model 3), the odds ratio (OR) per 1 standard deviation increment of CRP was 1.25 (95% CI 1.07–1.45, P=0.004). When the lowest CRP tertile group was used as the reference group, the OR of the highest CRP tertile group was 1.99 (95% CI 1.22–1.3.26, P=0.006). Adding CRP to the risk factor model increased the area under the ROC curve (0.68 vs 0.65, P=0.017). Subgroup analysis showed that the relationship between CRP and respiratory diseases had no potential heterogeneity among subgroups. CONCLUSIONS: CRP can be used as an effective biomarker in predicting risk of respiratory diseases in patients with diabetic retinopathy. International Scientific Literature, Inc. 2022-05-17 /pmc/articles/PMC9123838/ /pubmed/35578564 http://dx.doi.org/10.12659/MSM.935807 Text en © Med Sci Monit, 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Database Analysis
Chen, Kejia
Yan, Jiamin
Wu, Ling
Gu, Xingbo
Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy
title Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy
title_full Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy
title_fullStr Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy
title_full_unstemmed Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy
title_short Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy
title_sort relationship between c-reactive protein and respiratory diseases in patients with type 2 diabetic retinopathy
topic Database Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123838/
https://www.ncbi.nlm.nih.gov/pubmed/35578564
http://dx.doi.org/10.12659/MSM.935807
work_keys_str_mv AT chenkejia relationshipbetweencreactiveproteinandrespiratorydiseasesinpatientswithtype2diabeticretinopathy
AT yanjiamin relationshipbetweencreactiveproteinandrespiratorydiseasesinpatientswithtype2diabeticretinopathy
AT wuling relationshipbetweencreactiveproteinandrespiratorydiseasesinpatientswithtype2diabeticretinopathy
AT guxingbo relationshipbetweencreactiveproteinandrespiratorydiseasesinpatientswithtype2diabeticretinopathy